EFFECTIVE HALF-LIFE IN RADIOIODINE THERAPY OF THYROID

被引：0
|
作者：
HLISCS, R
HENNIG, K
机构：
来源：
RADIOLOGIA DIAGNOSTICA | 1978年 / 19卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [1] EFFICIENT HALF-LIFE PERIOD IN RADIOIODINE THERAPY OF THYROID
    HLISCS, R
    HENNIG, K
    [J]. DEUTSCHE GESUNDHEITSWESEN-ZEITSCHRIFT FUR KLINISCHE MEDIZIN, 1977, 32 (49): : 2336 - 2339
  • [2] Radioiodine therapy of benign thyroid disorders: What is the effective thyroidal half-life of 131I
    Kobe, C.
    Eschner, W.
    Sudbrock, F.
    Rahlff, I.
    Schmidt, M. C.
    Dietlein, M.
    Schicha, H.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S170 - S170
  • [3] Whole-Body Radioiodine Effective Half-Life in Patients with Differentiated Thyroid Cancer
    Klain, Michele
    Nappi, Carmela
    De Risi, Marina
    Piscopo, Leandra
    Volpe, Fabio
    Manganelli, Mariarosaria
    Caiazzo, Elisa
    Bianco, Davide
    Schlumberger, Martin
    Cuocolo, Alberto
    [J]. DIAGNOSTICS, 2021, 11 (10)
  • [4] RhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of 131I
    Menzel, C
    Kranert, WT
    Döbert, N
    Diehl, M
    Fietz, T
    Hamscho, N
    Berner, U
    Grünwald, F
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (07) : 1065 - 1068
  • [5] Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I?
    Kobe, Carsten
    Eschner, Wolfgang
    Wild, Markus
    Rahlff, Ilka
    Sudbrock, Ferdinand
    Schmidt, Matthias
    Dietlein, Markus
    Schicha, Harald
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2010, 31 (03) : 201 - 205
  • [6] Lithium as an adjunct to radioiodine therapy in Graves' disease for prolonging the intrathyroidal effective half-life of radioiodine -: Useful or not?
    Dunkelmann, S.
    Kuenstner, H.
    Nabovi, E.
    Eberlein, U.
    Groth, P.
    Schuemichen, C.
    [J]. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2006, 45 (05): : 213 - 218
  • [7] Analysis of Residence Time, Effective Half-Life, and Internal Dosimetry Before Radioiodine Therapy
    Oliveira, Caio Vinicius
    Cagol Camozzato, Tatiane Sabriela
    Dorow, Patricia Fernanda
    Pasqueta, Essica
    [J]. JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2022, 50 (03) : 233 - 239
  • [8] Thyroid Uptake and Effective Half-Life of Radioiodine in Thyroid Cancer Patients at Radioiodine Therapy and Follow-Up Whole-Body Scintigraphy Either in Hypothyroidism or Under rhTSH
    Bacher, Robin
    Hohberg, Melanie
    Dietlein, Markus
    Wild, Markus
    Kobe, Carsten
    Drzezga, Alexander
    Schmidt, Matthias
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (05) : 631 - 637
  • [9] Recombinant Human TSH Increases Uptake and Effective Half-life of Radioiodine in Thyroid Hormone Secreting Metastases of Follicular Thyroid Cancer
    Schneider, C.
    Dietlein, M.
    Eschner, W.
    Schmidt, M.
    Kahraman, D.
    Kobe, C.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2012, 120 (03) : 160 - 163
  • [10] Influence of antithyroid medication on effective half-life and uptake of I-131 following radioiodine therapy
    Moka, D
    Voth, E
    Schicha, H
    [J]. NUKLEARMEDIZIN, 1997, 36 (03) : 87 - 92
12345